Sanofi Pasteur MSD’s shingles jab OK’d for UK’s immunisation scheme
Sanofi Pasteur MSD’s shingles (herpes zoster) vaccine has been cleared for continued use in the UK’s national immunisation programme for at least the next two years, following an evaluation of the vaccine’s clinical and cost effectiveness.
Read More
